Tel Aviv Isreal-based Curesponse Ltd., a cancer precision medicine company, raised $6 million from investors including NCL Technology Ventures (UK) and aMoon (Israel) for scaling clinical trials and international expansion to the U.K. The company's platform, cResponse, is a functional cancer diagnostic which preserves the patient tumor in 3D for up to two weeks, allowing observation of the cancer microenvironment's response to cancer therapies.
Invacare Corp., of Elyria, Ohio, reported the completion of its previously announced separate private exchange transactions in which certain holders of its 5.0% convertible senior notes due 2021 and certain holders of its 4.5% convertible senior notes due 2022 exchanged approximately $35.4 million in aggregate principal amount of 2021 notes and $38.5 million in aggregate principal amount of 2022 notes, for aggregate consideration of approximately $73.9 million in aggregate principal amount of new 5.0% series II convertible senior exchange notes due 2024. Following the closing of these transactions, approximately $25.7 million in aggregate principal amount of the 2021 notes and $81.5 million in aggregate principal amount of the 2022 notes remain outstanding with terms unchanged. Invacare makes medical equipment used in non-acute care settings.
Mechanicsville, Va.-based Owens & Minor Inc., a global health care logistics company, has commenced offers to purchase for cash certain outstanding senior notes for a maximum aggregate purchase price, excluding accrued interest, of up to $240 million, and with respect to the 2021 notes, a consent solicitation upon the terms and conditions described in the company’s offer to purchase dated June 5, 2020. The tender offers to purchase the senior notes includes company’s 3.875% notes due in 2021 ($233.1 million aggregate amount outstanding) and 4.375% senior notes due in 2025 ($275 million outstanding, plus $15 million sub-cap). The offers will expire at 11:59 p.m. EST on July 2, unless extended or terminated by the company, and no tenders submitted after the expiration will be valid. The company intends to fund the tender offers with cash on hand, funds from its accounts receivable securitization program and at least $133 million in proceeds from the sale of its Movianto business. If the tender offers are not consummated or the amount of notes accepted for purchase comes in at less than the purchase price, the company may use the remaining proceeds from the Movianto sale to repay or retire other outstanding debt. Citigroup Global Markets is the dealer manager and solicitation agent in the tender offers and consent solicitation. D.F. King & Co. is serving as tender agent and information agent for the tender offers and consent solicitations.